Long-term serum proteomes are quite similar under high- and low-flux hemodialysis treatment

Proteomics - Clinical Applications

Volumn 4, Issue 12, 2010, Pages 953-961

  Hallbauer, Julia ^a   Kreusch, Stefan ^a   Klemm, Andree ^b   Wolf, Gunter ^a   Rhode, Heidrun ^a,c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Curatorium for Hemodialysis and Renal Transplantation   (Germany)

^c Scienova GmbH   (Germany)

Author keywords

2 microglobulin; Hemodialysis; High flux; Low flux; Serum proteome

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; POLYSULFONE; PROTEOME; SERUM ALBUMIN;

ADULT; AGED; AMINO ACID SEQUENCE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; REPRODUCIBILITY; SPECTROFLUOROMETRY; SPECTROMETRY;

AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; CROSS-OVER STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROTEOME; RENAL DIALYSIS; TOXINS, BIOLOGICAL;

EID: 78649695319     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000051     Document Type: Article

References (47)

1. Heinz, J., Domröse, U., Westphal, S., Luley, C. et al., Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology 2008, 13, 384-389.
2. Gil, H. W., Yang, J. O., Lee, E. Y., Lee, E. M. et al., The effect of dialysis membrane flux on amino acid loss in hemodialysis patients. J. Korean Med. Sci. 2007, 22, 598-603.
3. Hörl, W. H., Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J. Am. Soc. Nephrol. 2002, 13, S62-S71.
4. Ishikawa, I., Chikazawa, Y., Sato, K., Nakagawa, M. et al., Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and pmma) during hemodialysis treatment using SELDI-TOF-MS. Am. J. Nephrol. 2006, 26, 372-380.
5. Vanholder, R., Van Laecke, S., Glorieux, G., The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J. Nephrol. 2008, 21, 146-160.
6. Vanholder, R., De Smet, R., Glorieux, G., Argilés, A. et al., European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003, 63, 1934-1943.
7. Vanholder, R., Van Laecke, S., Glorieux, G., What is new in uremic toxicity? Pediatr. Nephrol. 2008, 23, 1211-1221.
8. Winchester, J. F., Audia, P. F., Extracorporeal strategies for the removal of middle molecules. Semin. Dial. 2006, 19, 110-114.
9. Locatelli, F., Manzoni, C., Cavalli, A., Di Filippo, S., Can convective therapies improve dialysis outcomes? Curr. Opin. Nephrol. Hypertens. 2009, 18, 476-480.
10. Tattersall, J., Canaud, B., Heimburger, O., Petrini, L. et al., High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study. Nephrol. Dial. Transplant. 2010, 25, 1230-1232.
11. Locatelli, F., Gauly, A., Czekalski, S., Hannedouche, T. et al., The MPO study: just a European HEMO study or something very different? Blood Purif. 2008, 26, 100-104.
12. Ouseph, R., Hutchison, C. A., Ward, R. A., Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers. Nephrol. Dial. Transplant. 2008, 23, 1704-1712.
13. Lindstrom, V., Grubb, A., Alquist Hegbrant, M., Christensson, A., Different elimination patterns of beta-trace protein, beta(2)-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand. J. Clin. Lab. Invest. 2008, 2, 1-7.
14. Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T. et al., Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 2002, 347, 2010-2019.
15. Horn, A., Kreusch, S., Bublitz, R., Hoppe, H. et al., Multidimensional proteomics of human serum using parallel chromatography of native constituents and microplate technology. Proteomics 2006, 6, 559-570.
16. Kreusch, S., Schulze, M., Cumme, G. A., Ditze, G. et al., Searching biomarker candidates in serum using multidimensional native chromatography I enhanced separation method. J. Chromatogr. B 2008, 875, 567-572.
17. Baum, A., Pohl, M., Kreusch, S., Cumme, G. A. et al., Searching biomarker candidates in serum using multidimensional native chromatography II method evaluation with Alport Syndrome and severe inflammation. J. Chromatogr. B 2008, 876, 31-40.
18. Kreusch, S., Schwedler, S., Tautkus, B., Cumme, G. A. et al., UV measurements in microplates suitable for high-throughput protein determination. Anal. Biochem. 2003, 313, 208-215.
19. Yanagisawa, K., Makita, Z., Shiroshita, K., Ueda, T. et al., Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 1998, 47, 1348-1353.
20. Bublitz, R., Kreusch, S., Ditze, G., Schulze, M. et al., Robust protein quantitation in chromatographic Fractions using matrix-assisted laser desorption/ionization mass spectrometry of tryptic peptides. Proteomics 2006, 6, 3909-3917.
21. Cumme, G. A., Kreusch, S., Nagel, M., Rhode, H., Multidimensional chromatography: Validation and efficient fishing for biomarkers and fractions containing them using the VisualCockpit software package. Proteomics 2008, 8, 37-41.
22. Mandolfo, S., Borlandelli, S., Imbasciati, E., Leptin and beta2-microglobulin kinetics with three different dialysis modalities. Int. J. Artif. Organs 2006, 29, 949-955.
23. Haase, M., Bellomo, R., Baldwin, I., Haase-Fielitz, A. et al., Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis. Int. J. Artif. Organs. 2007, 30, 385-392.
24. Ayli, D., Ayli, M., Azak, A., Yüksel, C. et al., The effect of high-flux hemodialysis on renal anemia. J. Nephrol. 2004, 17, 701-706.
25. Locatelli, F., Andrulli, S., Pecchini, F., Pedrini, L. et al., Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol. Dial. Transplant. 2000, 15, 1399-1409.
26. Traut, M., Haufe, C. C., Eismann, U., Deppisch, R. M. et al., Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Blood Purif. 2007, 25, 432-440.
27. Krieter, D. H., Hackl, A., Rodriguez, A., Chenine, L. et al., Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol. Dial. Transplant. 2010, 25, 212-218.
28. Mann, H., Melzer, H., Al-Bashir, A., Xu, X. Q., et al., Testing protein permeability of dialysis membranes using SDS-PAGE. Int. J. Artif. Organs 2002, 25, 441-446.
29. Lesaffer, G., De Smet, R., Lameire, N., Dhondt, A. et al., Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol. Dial. Transplant. 2000, 15, 50-57.
30. Ayli, M., Ayli, D., Azak, A., Yüksel, C. et al., The effect of high-flux hemodialysis on dialysis-associated amyloidosis. Ren. Fail. 2005, 27, 31-34.
31. Kaiser, T., Hermann, A., Kielstein, J. T., Wittke, S. et al., Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. J. Chromatogr. A 2003, 1013, 157-171.
32. House, A. A., Wells, G. A., Donnelly, J. G., Nadler, S. P. et al., Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids. Nephrol. Dial. Transplant. 2000, 15, 1029-1034.
33. Lippi, G., Tessitore, N., Salvagno, G. L., Bedogna, V. et al., Influence of haemodialysis on high-sensitivity C-reactive protein, lipoprotein(a), apolipoproteins A and B. Clin. Biochem. 2007, 40, 1336-1338.
34. Winchester, J. F., Silberzweig, J., Ronco, C., Kuntsevich, V. et al., Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal. Blood Purif. 2004, 22, 73-77.
35. Li, P. K., Cheng, Y. L., Leung, C. B., Szeto, C. C. et al., Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial. Clin. J. Am. Soc. Nephrol. 2010, 5, 652-658.
36. Gerszten, R. E., Accurso, F., Bernard, G. R., Caprioli, R. M. et al., Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 295, L16-22.
37. Bonomini, M., Ballone, E., Di Stante, S., Bucciarelli, T. et al., Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. Nephrol. Dial. Transplant. 2004, 19, 68-74.
38. Ru, Q. H., Wang, Y. M., Luo, G. A., Wang, S. X. et al., Establishment of an interaction model of human apolipoprotein H with lipid monolayer by capillary SDS gel electrophoresis. J. Capill. Electrophor. Microchip Technol. 2002, 7, 37-41.
39. Kruse, A., Uehlinger, D. E., Gotch, F., Kotanko, P. et al., Red blood cell lifespan, erythropoiesis and hemoglobin control. Contrib. Nephrol. 2008, 161, 247-254.
40. Hoenich, N. A., Revisiting the role of flux in beta2-microglobulin removal. Blood Purif. 2007, 25, 430-431.
41. van Tellingen, A., Schalkwijk, C. G., Teerlink, T., Barto, R. et al., Influence of different haemodialysis modalities on AGE peptide levels: intradialytic versus long-term results. Nephron. Clin. Pract. 2005, 100, c1-c7.
42. Bohlender, J., Franke, S., Stein, G., Wolf, G., Advanced glycation end products and the kidney. Am. J. Physiol. (Renal) 2005, 289, F645-F659.
43. Raff, A. C., Meyer, T. W., Hostetter, T. H., New insights into uremic toxicity. Curr. Opin. Nephrol. Hypertens. 2008, 17, 560-565.
44. Locatelli, F., Martin-Malo, A., Hannedouche, T., Loureiro, A. et al., Effect of membrane permeability on survival of hemodialysis patients. J. Am. Soc. Nephrol. 2009, 20, 645-654.
45. Stavroulopoulos, A., Petras, D., Kakavas, I., Agroyannis, I. et al., Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of atorvastatin administration. Blood Purif. 2010, 29, 274-279.
46. Canaud, B., Bragg-Gresham, J. L., Marshall, M. R., Desmeules, S. et al., Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006, 69, 2087-2093.
47. Santoro, A., Mancini, E., Bolzani, R., Boggi, R. et al., The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am. J. Kidney Dis. 2008, 52, 507-518.